Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) COO John R. Gallagher sold 3,100 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $32.99, for a total transaction of $102,269.00. Following the completion of the sale, the chief operating officer now owns 25,549 shares in the company, valued at $842,861.51. The trade was a 10.82 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Trupanion Stock Up 2.7 %
TRUP stock opened at $34.09 on Thursday. Trupanion, Inc. has a 52-week low of $19.69 and a 52-week high of $57.90. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. The firm has a market capitalization of $1.45 billion, a P/E ratio of -148.22, a P/E/G ratio of 6.02 and a beta of 1.70. The company’s 50 day simple moving average is $43.21 and its 200-day simple moving average is $47.24.
Trupanion (NASDAQ:TRUP – Get Free Report) last released its earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The company had revenue of $337.31 million during the quarter, compared to analysts’ expectations of $335.41 million. As a group, equities research analysts anticipate that Trupanion, Inc. will post 0.13 EPS for the current year.
Institutional Investors Weigh In On Trupanion
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on the stock. Piper Sandler cut their price target on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a report on Thursday, February 20th. Stifel Nicolaus cut their price target on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a report on Thursday, February 20th. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $46.60.
View Our Latest Analysis on TRUP
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Stories
- Five stocks we like better than Trupanion
- 10 Best Airline Stocks to Buy
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- How to Start Investing in Real Estate
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- Canadian Penny Stocks: Can They Make You Rich?
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.